A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria
Status:
Terminated
Trial end date:
2021-02-24
Target enrollment:
Participant gender:
Summary
The reason for this study is to see if the study drug LY3454738 is safe and effective as
treatment for participants with hives that are caused by chronic spontaneous urticaria (CSU)
and that are not controlled with H1-antihistamines.